Results 271 to 280 of about 78,818 (344)

Role of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources. [PDF]

Drug Des Devel Ther
Fakih TM, Novitasari D, Syaifudin M, Meiyanto E, Astirin OP, Mohd Gazzali A, Muchtaridi M.   +6 more
europepmc   +1 more source

DOE SBIR Phase I Grant No. DE-FG02-00ER83067, ''A Flexible and Economical Automated Nucleophilic [{sup 18}F]Fluorination synthesis System for PET Radiopharmaceuticals.'' Final Technical Report

, 2001
Henry C. Padgett
openalex   +2 more sources

Currently Available Radiopharmaceuticals for Imaging Infection and the Holy Grail.

Seminars in nuclear medicine, 2018
Ebru Salmanoglu, S. Kim, M. Thakur
semanticscholar   +1 more source

Production of ⁶⁴Cu and ⁶⁷Cu with accelerator neutrons by deuterons and their separation from zinc. [PDF]

Front Nucl Med
Nagai Y, Kawabata M, Saeki H, Motoishi S, Hashimoto K, Tsukada K, Motomura A, Ohta A, Takashima N, Hashimoto S, Itoh M, Kikunaga H, Furumoto S.   +12 more
europepmc   +1 more source

8. Radiopharmaceuticals. (1) SPECT

, 2001
Akira Yokoyama
openalex   +2 more sources

Is Copper-61 the New Gallium-68? Automation and Preclinical Proof-of-Concept of ⁶¹Cu-Based Radiopharmaceuticals for Prostate Cancer Imaging. [PDF]

Pharmaceuticals (Basel)
Rodrigues D, Fonseca AI, do Carmo S, Sereno J, Hrynchak I, Moreira JN, Gomes C, Abrunhosa A.   +7 more
europepmc   +1 more source

Peritoneal Equilibration Test Using the Radiopharmaceutical, Diethylene-triaminepentaacetate (DTPA)

, 2003
Rajinder Kumar Sharma, Tarun Jeloka, Amit Gupta, M.S. Sentilnathan, P.K. Pradhan, Bikash Das   +5 more
openalex   +1 more source

Adverse Reactions by Radiopharmaceuticals: Retrospective Analysis of the Portuguese National Pharmacovigilance System. [PDF]

Ann Pharmacother
Martins S, Jesus Â, Andrade R, Rocha M, Martín-Suarez A.   +4 more
europepmc   +1 more source

Synthesis and Characterization of Rhenium(V) Complexes Having 3-(4-m-Chlorophenylpiperazin-1-yl)butane-1-thiol as Coligand toward 5HT_2ASpecific Radiopharmaceuticals

, 2003

openalex   +2 more sources

Based on small molecules: development and application of fibroblast activation protein inhibitors radiopharmaceutical in tumor precision therapy. [PDF]

Front Pharmacol
Luo Y, Fu H, Yu C.
europepmc   +1 more source